Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A Infection

MHAA4549A is a human anti‐influenza A monoclonal antibody developed to treat influenza A. We report MHAA4549A serum, nasopharyngeal, and tracheal aspirate pharmacokinetics from a phase 2b study in hospitalized patients with severe influenza A. Patients were randomized 1:1:1 into 3 groups receiving s...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Rong, She, Gaohong, Maia, Mauricio, Lim, Jeremy J., Peck, Melicent C., McBride, Jacqueline M., Kulkarni, Priya, Horn, Priscilla, Castro, Aide, Newton, Elizabeth, Tavel, Jorge A., Hanley, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
NON COVID ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586956/
https://www.ncbi.nlm.nih.gov/pubmed/32621543
http://dx.doi.org/10.1002/jcph.1652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586956/
https://www.ncbi.nlm.nih.gov/pubmed/32621543
http://dx.doi.org/10.1002/jcph.1652

Ejemplares similares